![Steven John Green](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steven John Green
Directeur/Membre du Conseil chez
Biogen Idec Ltd.
Profil
Steven John Green is currently a Director at Biogen Idec Ltd., Convergence Pharmaceuticals Ltd., Amicus Therapeutics International Holding Ltd., Silver Acquisition Co. Ltd., Convergence Pharmaceuticals Holdings Ltd., and Old Convergence Pharmaceuticals Ltd. He was previously a Director at Nightstar Therapeutics Ltd. from 2019 to 2020.
Postes actifs de Steven John Green
| Sociétés | Poste | Début |
|---|---|---|
Biogen Idec Ltd.
 Biogen Idec Ltd. BiotechnologyHealth Technology Develops therapies for neurodegenerative, haematologic, and autoimmune disorders | Directeur/Membre du Conseil | 27/07/2011 |
Convergence Pharmaceuticals Holdings Ltd.
 Convergence Pharmaceuticals Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Directeur/Membre du Conseil | - |
Silver Acquisition Co. Ltd.
 Silver Acquisition Co. Ltd. BiotechnologyHealth Technology Provides research and experimental development on biotechnology | Directeur/Membre du Conseil | 19/12/2014 |
Convergence Pharmaceuticals Ltd.
 Convergence Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops neuropathic pain products | Directeur/Membre du Conseil | 06/01/2015 |
Old Convergence Pharmaceuticals Ltd.
 Old Convergence Pharmaceuticals Ltd. Miscellaneous Commercial ServicesCommercial Services Develops analgesics for the treatment of chronic pain | Directeur/Membre du Conseil | 12/04/2018 |
Amicus Therapeutics International Holding Ltd.
 Amicus Therapeutics International Holding Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Directeur/Membre du Conseil | 01/06/2020 |
Anciens postes connus de Steven John Green
| Sociétés | Poste | Fin |
|---|---|---|
| NIGHTSTAR THERAPEUTICS PLC | Directeur/Membre du Conseil | 24/04/2020 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
13
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Biogen Idec Ltd.
Biogen Idec Ltd. BiotechnologyHealth Technology Develops therapies for neurodegenerative, haematologic, and autoimmune disorders | Health Technology |
Convergence Pharmaceuticals Ltd.
Convergence Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops neuropathic pain products | Health Technology |
Amicus Therapeutics International Holding Ltd.
Amicus Therapeutics International Holding Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Silver Acquisition Co. Ltd.
Silver Acquisition Co. Ltd. BiotechnologyHealth Technology Provides research and experimental development on biotechnology | Health Technology |
Convergence Pharmaceuticals Holdings Ltd.
Convergence Pharmaceuticals Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Nightstar Therapeutics Ltd.
 Nightstar Therapeutics Ltd. BiotechnologyHealth Technology Operates as a gene therapy company that develops novel treatments for patients suffering from inherited retinal diseases | Health Technology |
Old Convergence Pharmaceuticals Ltd.
Old Convergence Pharmaceuticals Ltd. Miscellaneous Commercial ServicesCommercial Services Develops analgesics for the treatment of chronic pain | Commercial Services |
